![Pierre Jaccoud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Pierre Jaccoud first degree
Entity | Entity type | Industry | |
---|---|---|---|
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
57
| Subsidiary | Pharmaceuticals: Major | 57 |
Clinerion AG
![]() Clinerion AG Packaged SoftwareTechnology Services Clinerion AG develops software and solutions for pharmacovigilance. It provides consulting and outsourcing services for pharmaceutical industry and non-governmental organizations. The firm offers its own client-tailored software solutions for improvement of quality, compliance & performance of clinical trials operations. The company was founded in 2008 and is headquartered in Basel, Switzerland.
4
| Subsidiary | Packaged Software | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pierre Jaccoud via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Chairman Human Resources Officer | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Holdings, Inc.
![]() Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chief Executive Officer Chairman | |
MedGenesis Therapeutix, Inc.
![]() MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
Gen-Probe, Inc.
![]() Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chairman Compliance Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Comptroller/Controller/Auditor | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
Diethelm Keller Holding AG
![]() Diethelm Keller Holding AG Miscellaneous Commercial ServicesCommercial Services Diethelm Keller Holding Ltd. holding company with interest in providing brand management, marketing, logistics and travel services. The firm brands include EDAK, Koenig, Turmix, Zyliss, Wetrok, Delta and Gloster. The company is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Roche Diagnostics Corp.
![]() Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Executive Officer President | |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer Chief Executive Officer | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Masters Business Admin | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
TeGenero AG
![]() TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Glycart AG
![]() Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Roche Ventures
![]() Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree Doctorate Degree | |
University of Innsbruck | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
University of Basel | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
Freie Universität Berlin | College/University | Doctorate Degree Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Amgen Rockville, Inc.
![]() Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal | ||
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
Friends of Phelophepa Foundation | Chairman Chairman | ||
Humer Foundation | Chairman Director/Board Member | ||
Commission For Technology & Innovation | Director/Board Member Corporate Officer/Principal | ||
PIQUR Therapeutics AG
![]() PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Founder Chairman Director/Board Member | |
Minoryx Therapeutics SL
![]() Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Targimmune Therapeutics AG
![]() Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Founder Chairman | |
TOLREMO therapeutics AG
![]() TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Founder Director/Board Member | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal |
Statistics
International
Switzerland | 19 |
United States | 15 |
Germany | 9 |
France | 3 |
Belgium | 3 |
Sectoral
Health Technology | 28 |
Consumer Services | 11 |
Commercial Services | 6 |
Finance | 5 |
Operational
Director/Board Member | 387 |
Corporate Officer/Principal | 163 |
Chairman | 116 |
Independent Dir/Board Member | 74 |
Chief Executive Officer | 59 |
Most connected contacts
Insiders | |
---|---|
Franz Humer | 45 |
Bradley Bolzon | 41 |
Jean-Luc Bélingard | 40 |
Erich Maximilian Platzer | 31 |
Erich Hunziker | 28 |
Carole Nüchterlein | 27 |
Leonard Patrick Gage | 26 |
Gottlieb A. Keller | 26 |
Severin Schwan | 23 |
Pamela Kirby | 22 |
Herbert Conrad | 21 |
Richard T. Laube | 21 |
Heino von Prondzynski | 19 |
Eric Forquenot de la Fortelle | 19 |
Patrick Baeuerle | 19 |
- Stock Market
- Insiders
- Pierre Jaccoud
- Company connections